Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation Targeting Restitution Parameter-Guided Catheter Ablation: CUVIA-REGAB Prospective Randomized Study

다국어 초록 (Multilingual Abstract)

Background and Objectives: We investigated whether extra-pulmonary vein (PV) ablation targeting a high maximal slope of the action potential duration restitution curve (Smax) improves the rhythm outcome of persistent atrial fibrillation (PeAF) ablation.
Methods: In this open-label, multi-center, randomized, and controlled trial, 178 PeAF patients were randomized with 1:1 ratio to computational modeling-guided virtual Smax ablation (V-Smax) or empirical ablation (E-ABL) groups. Smax maps were generated by computational modeling based on atrial substrate maps acquired during clinical procedures in sinus rhythm. Smax maps were generated during the clinical PV isolation (PVI). The V-Smax group underwent an additional extra-PV ablation after PVI targeting the virtual high Smax sites.
Results: After a mean follow-up period of 12.3±5.2 months, the clinical recurrence rates (25.6% vs. 23.9% in the V-Smax and the E-ABL group, p=0.880) or recurrence appearing as atrial tachycardia (11.1% vs. 5.7%, p=0.169) did not differ between the 2 groups. The post-ablation cardioversion rate was higher in the V-Smax group than E-ABL group (14.4% vs. 5.7%, p=0.027). Among antiarrhythmic drug-free patients (n=129), the AF freedom rate was 78.7% in the V-Smax group and 80.9% in the E-ABL group (p=0.776). The total procedure time was longer in the V-Smax group (p=0.008), but no significant difference was found in the major complication rates (p=0.497) between the groups.
Conclusions: Unlike a dominant frequency ablation, the computational modeling-guided V-Smax ablation did not improve the rhythm outcome of the PeAF ablation and had a longer procedure time.

참고문헌 (Reference)

1 Shim J, "Virtual in-silico modeling guided catheter ablation predicts effective linear ablation lesion set for longstanding persistent atrial fibrillation : multicenter prospective randomized study" 8 : 792-, 2017

2 Narayan SM, "Treatment of atrial fibrillation by the ablation of localized sources : CONFIRM. (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)trial" 60 : 628-636, 2012

3 Li C, "The spatiotemporal stability of dominant frequency sites in in-silico modeling of 3-dimensional left atrial mapping of atrial fibrillation" 11 : e0160017-, 2016

4 Lee JM, "The electrical isolation of the left atrial posterior wall in catheter ablation of persistent atrial fibrillation" 5 : 1253-1261, 2019

5 Hwang I, "Spatial changes in the atrial fibrillation wave-dynamics after using antiarrhythmic drugs : a computational modeling study" 12 : 733543-, 2021

6 Park JW, "Restitution slope affects the outcome of dominant frequency ablation in persistent atrial fibrillation : CUVIA-AF2 post-hoc analysis based on computational modeling study" 9 : 838646-, 2022

7 Narayan SM, "Repolarization and activation restitution near human pulmonary veins and atrial fibrillation initiation : a mechanism for the initiation of atrial fibrillation by premature beats" 52 : 1222-1230, 2008

8 Krummen DE, "Mechanisms of human atrial fibrillation initiation : clinical and computational studies of repolarization restitution and activation latency" 5 : 1149-1159, 2012

9 Kim D, "Less dementia after catheter ablation for atrial fibrillation : a nationwide cohort study" 41 : 4483-4493, 2020

10 Lim B, "In situ procedure for high-efficiency computational modeling of atrial fibrillation reflecting personal anatomy, fiber orientation, fibrosis, and electrophysiology" 10 : 2417-, 2020

11 Kannel WB, "Epidemiologic features of chronic atrial fibrillation : the Framingham study" 306 : 1018-1022, 1982

12 Lim B, "Effectiveness of atrial fibrillation rotor ablation is dependent on conduction velocity : an in-silico 3-dimensional modeling study" 12 : e0190398-, 2017

13 Packer DL, "Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation : the CABANA randomized clinical trial" 321 : 1261-1274, 2019

14 Kim TH, "Does additional electrogram-guided ablation after linear ablation reduce recurrence after catheter ablation for longstanding persistent atrial fibrillation? A prospective randomized study" 6 : 6-, 2017

15 Pak HN, "Cryoballoon versus high-power, short-duration radiofrequency ablation for pulmonary vein isolation in patients with paroxysmal atrial fibrillation : a single-center, prospective, randomized study" 14 : e010040-, 2021

16 Kim IS, "Clinical usefulness of computational modeling-guided persistent atrial fibrillation ablation : updated outcome of multicenter randomized study" 10 : 1512-, 2019

17 Baek YS, "Clinical outcomes of computational virtual mapping-guided catheter ablation in patients with persistent atrial fibrillation : a multicenter prospective randomized clinical trial" 8 : 772665-, 2021

18 Weiss JN, "Chaos and the transition to ventricular fibrillation : a new approach to antiarrhythmic drug evaluation" 99 : 2819-2826, 1999

19 Qu Z, "Cardiac electrical restitution properties and stability of reentrant spiral waves : a simulation study" 276 : H269-83, 1999

20 Marrouche NF, "Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation : the DECAAF study" 311 : 498-506, 2014

21 Verma A, "Approaches to catheter ablation for persistent atrial fibrillation" 372 : 1812-1822, 2015

22 Kim BS, "Action potential duration restitution kinetics in human atrial fibrillation" 39 : 1329-1336, 2002